Jasplakinolide: Membrane-Permeable Actin Polymerization Inducer

Executive Summary: Jasplakinolide is a cyclodepsipeptide isolated from the marine sponge Jaspis johnstoni and acts as a potent inducer of actin polymerization and stabilizer of F-actin filaments (ApexBio B7189). The compound binds F-actin with an affinity (K_d) of approximately 15 nM, surpassing phalloidin in potency under many conditions. Jasplakinolide is membrane-permeable, enabling intracellular actin modulation in live cells, and exhibits distinct effects on Mg²⁺- versus Ca²⁺-actin. It is used extensively in cytoskeletal dynamics research, but its cytotoxicity at higher concentrations and competitive binding with phalloidin require careful protocol design (Zheng et al., 2006).

Biological Rationale

The actin cytoskeleton is essential for cell shape, motility, intracellular transport, and division. Actin exists in dynamic equilibrium between its monomeric (G-actin) and filamentous (F-actin) forms. Modulating actin dynamics is critical for dissecting cellular processes such as migration, cytokinesis, and mechanotransduction (Jasplakinolide: Redefining Actin Cytoskeleton Modulation ...). Jasplakinolide is unique among actin-binding compounds due to its ability to permeate cell membranes and induce actin polymerization in both live and fixed cells. This enables researchers to study cytoskeletal rearrangements in real time and under physiologically relevant conditions. Unlike phalloidin, which is not membrane-permeable, Jasplakinolide can be used in living cells to directly modulate endogenous actin structures.

Mechanism of Action of Jasplakinolide

Jasplakinolide acts as an actin polymerization inducer and F-actin stabilizer. It binds to F-actin with a dissociation constant (K_d) of ~15 nM, competitively inhibiting phalloidin binding sites (Zheng et al., 2006). The compound promotes actin nucleation and elongation, resulting in increased filament assembly, especially in the presence of Mg²⁺ ions. Jasplakinolide's interaction with F-actin prevents filament depolymerization, thus stabilizing existing actin structures. It is more effective on Mg²⁺-actin than on Ca²⁺-actin, reflecting differences in actin isoform conformation and binding affinity. Jasplakinolide is highly soluble in DMSO and appears as an off-white solid. The compound is membrane-permeable, allowing for intracellular delivery and rapid actin cytoskeleton modulation (ApexBio B7189).

Evidence & Benchmarks

• Jasplakinolide induces actin polymerization in vitro within minutes at concentrations as low as 50 nM (Table 1, https://doi.org/10.1104/pp.106.080390).
• It stabilizes preformed actin filaments against depolymerization, with half-maximal stabilization reached at ~15 nM K_d (Figure 2, https://doi.org/10.1104/pp.106.080390).
• Jasplakinolide is membrane-permeable and induces actin polymerization in live mammalian cells within 10–30 minutes post-application (ApexBio B7189).
• It displays fungicidal and antiproliferative activity, likely due to cytoskeletal disruption at concentrations ≥100 nM (https://doi.org/10.1104/pp.106.080390).
• Competitive binding with phalloidin has been confirmed in multiple biochemical assays (see Figure 4, https://doi.org/10.1104/pp.106.080390).

This article extends the mechanistic detail found in Jasplakinolide: Precision Actin Modulation for Cell Signa... by providing quantitative benchmarks for F-actin stabilization and live-cell delivery kinetics. For a comparison of membrane permeability and imaging applications, see Jasplakinolide: The Premier Actin Polymerization Inducer ..., which this article updates with current best practices and cytotoxicity thresholds.

Applications, Limits & Misconceptions

Jasplakinolide is widely used in cytoskeletal dynamics studies, cell motility assays, and imaging workflows. Its membrane permeability enables studies in both live and fixed cells. The compound is valuable for dissecting actin-dependent processes, such as lamellipodia formation, cytokinesis, and chemotaxis. At higher concentrations, Jasplakinolide exerts cytotoxic effects, including inhibition of cell proliferation and induction of apoptosis in sensitive cell types. It is also used as a fungicidal agent in plant and fungal research. However, misconceptions persist regarding its specificity—Jasplakinolide does not exclusively target actin in all cellular contexts, and off-target effects may occur at supraphysiological doses.

Common Pitfalls or Misconceptions

• Jasplakinolide is sometimes incorrectly assumed to be non-toxic at all working concentrations; in reality, cytotoxicity can emerge at ≥100 nM in sensitive lines.
• It cannot distinguish between actin isoforms or post-translational modifications—binding is based on F-actin conformation.
• Jasplakinolide binding is competitive with phalloidin; co-application may confound imaging or biochemical assays.
• It is not suitable for direct in vivo systemic administration in animal models due to rapid toxicity.
• Storage above –20°C or in aqueous buffers degrades the compound and reduces efficacy.

Workflow Integration & Parameters

Jasplakinolide should be dissolved in DMSO at 1–10 mM stock concentration and stored at –20°C protected from light. For cell-based assays, final working concentrations typically range from 20–200 nM, with incubation times from 10–60 minutes depending on cell type and experimental endpoint (ApexBio B7189). Optimization is required for each application to balance actin stabilization with cell viability. Control experiments with DMSO vehicle and phalloidin competition are recommended. Jasplakinolide is compatible with live-cell imaging and super-resolution microscopy. For advanced protocol integration, consult Jasplakinolide: Actin Polymerization Inducer for Cytoskel..., which this article clarifies by specifying cytotoxicity thresholds and storage requirements.

Conclusion & Outlook

Jasplakinolide is a validated, membrane-permeable actin polymerization inducer and F-actin stabilizer, offering unmatched potency and flexibility for cytoskeletal research. Its nanomolar binding affinity and robust cellular uptake enable studies of actin dynamics under physiological conditions. However, users must account for cytotoxicity, competitive binding, and storage constraints. Future research will further delineate isoform specificity and expand applications in disease modeling. For ordering and technical details, consult the Jasplakinolide B7189 kit.